# OnCo record nct04373369 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct04373369/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct04373369", "NCT04373369" ;
  schema:name "Vorolanib + Atezolizumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer"@en ;
  schema:description "A phase 2 trial of Vorolanib and Atezolizumab in Extensive-stage small-cell lung cancer, run by Washington University School of Medicine, recorded as terminated on the registry."@en ;
  schema:url <https://onco.cc/trials/nct04373369/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04373369> ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "2" ;
  onco:cancers <https://onco.cc/cancers/extensive-stage-sclc/> ;
  onco:drugs <https://onco.cc/drugs/vorolanib/>, <https://onco.cc/drugs/atezolizumab/> .